During the past decade, Dianutrilife Medica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dianutrilife Medica" are "Diabetes Mellitus, Type 2" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Dianutrilife Medica" in a lesser frequency.

Most popular intervention types in "Dianutrilife Medica" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "Insulin Glargine (U100)" (1 trials), "Insulin Lispro (U100)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dianutrilife Medica" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Dianutrilife Medica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dianutrilife Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dianutrilife Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".